Abou Saleh M, Mansoor E, Anindo M, Isenberg G (2019) Prevalence of small intestine carcinoid tumors: a US population-based study 2012–2017. Dig Dis Sci 64:1328–1334
Deguelte S, Perrier M, Hammoutene C, Cadiot G, Kianmanesh R (2020) Surgery and perioperative management in small intestinal neuroendocrine tumors. J Clin Med. https://doi.org/10.3390/jcm9072319
Article PubMed PubMed Central Google Scholar
Soreide K, Stattner S, Hallet J (2024) Surgery as a principle and technical consideration for primary tumor resection of small bowel neuroendocrine tumors. Ann Surg Oncol 31:1125–1137
Almond LM, Hodson J, Ford SJ et al (2017) Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: a systematic review and meta-analysis. Eur J Surg Oncol 43:1808–1815
Bennett S, Coburn N, Law C et al (2022) Upfront small bowel resection for small bowel neuroendocrine tumors with synchronous metastases: a propensity-score matched comparative population-based analysis. Ann Surg 276:e450–e458
Danieli M, Fumagalli Romario U, Radice D et al (2024) Surgical and oncologic outcomes of primary tumor resection in patients with small intestinal neuroendocrine tumors: results from a single-center series over a 15-year period. Ann Surg Oncol. https://doi.org/10.1245/s10434-024-16588-9
Eriksson J, Garmo H, Hellman P, Ihre-Lundgren C (2017) The influence of preoperative symptoms on the death of patients with small intestinal neuroendocrine tumors. Ann Surg Oncol 24:1214–1220
Nigam A, Li JWY, Fiasconaro M et al (2024) Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors. Ann Surg Oncol 31:2337–2348
Russo A, DiPeri T, Dumitra T et al (2024) Impact of primary tumor resection in the management of metastatic well-differentiated neuroendocrine tumors of the small bowel and pancreas. J Neuroendocrinol 36:e13399
Snorradottir S, Asgeirsdottir A, Rognvaldsson S, Jonasson JG, Bjornsson ES (2022) Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study. Cancer Epidemiol 79:102197
Manguso N, Gangi A, Nissen N et al (2018) Long-term outcomes after elective versus emergency surgery for small bowel neuroendocrine tumors. Am Surg 84:1570–1574
Le Roux C, Lombard-Bohas C, Delmas C et al (2011) Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study. Dig Liver Dis 43:828–833
Butz F, Supper L, Reinhard L et al (2024) Emergency surgery influences oncological outcome in small intestinal neuroendocrine tumors. Scand J Surg 113:303–313
Addeo P, Poncet G, Goichot B et al (2018) The added diagnostic value of (18)F-fluorodihydroxyphenylalanine PET/CT in the preoperative work-up of small bowel neuroendocrine tumors. J Gastrointest Surg 22:722–730
Ouvrard E, Mestier L, Boursier C et al (2022) (18)F-DOPA PET/CT at the forefront of initial or presurgical evaluation of small-intestine neuroendocrine tumors. J Nucl Med 63:1865–1870
Alves A, Panis Y, Mantion G, Slim K, Kwiatkowski F, Vicaut E (2007) The AFC score: validation of a 4-item predicting score of postoperative mortality after colorectal resection for cancer or diverticulitis: results of a prospective multicenter study in 1049 patients. Ann Surg 246:91–96
PubMed PubMed Central Google Scholar
Ohrvall U, Eriksson B, Juhlin C et al (2000) Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg 24:1402–1408
Lardiere-Deguelte S, de Mestier L, Appere F et al (2016) Toward a preoperative classification of lymph node metastases in patients with small intestinal neuroendocrine tumors in the era of intestinal-sparing surgery. Neuroendocrinology 103:552–559
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
PubMed PubMed Central Google Scholar
Frilling A, Li J, Malamutmann E, Schmid KW, Bockisch A, Broelsch CE (2009) Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg 96:175–184
Lamarca A, Bartsch DK, Caplin M et al (2024) European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours. J Neuroendocrinol 36:e13423
Catena F, Ansaloni L, Gazzotti F et al (2005) Small bowel tumours in emergency surgery: specificity of clinical presentation. ANZ J Surg 75:997–999
Deguelte S, Metoudi A, Rhaiem R et al (2022) Small intestinal neuroendocrine neoplasm: factors associated with the development of local tumor-related symptoms. Neuroendocrinology 112:252–262
Comments (0)